FGF23 and Klotho in relation to markers of endothelial dysfunction in kidney transplant recipients

Transplantation Proceedings

Volumn 46, Issue 8, 2014, Pages 2647-2650

  Malyszko, Jolanta ^a   Koc Zorawska, E ^a   Matuszkiewicz Rowinska, J ^b   Malyszko, Jacek ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; AZATHIOPRINE; CALCIUM; COPEPTIN; CREATININE; CYCLOSPORIN A; FIBROBLAST GROWTH FACTOR 23; HEMOGLOBIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; KLOTHO PROTEIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PHOSPHATE; PREDNISONE; TACROLIMUS; UREA; VASCULAR CELL ADHESION MOLECULE 1; VON WILLEBRAND FACTOR; BETA GLUCURONIDASE; BIOLOGICAL MARKER; FIBROBLAST GROWTH FACTOR; FIBROBLAST GROWTH FACTOR RECEPTOR 1; IMMUNOSUPPRESSIVE AGENT;

ADULT; CLINICAL LABORATORY; COMORBIDITY; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATIONAL STUDY; DISEASE ASSOCIATION; ENDOTHELIAL DYSFUNCTION; FEMALE; GLOMERULUS FILTRATION RATE; GRAFT FAILURE; GRAFT RECIPIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; MEAN CORPUSCULAR VOLUME; THROMBOCYTE COUNT; BLOOD; ENDOTHELIUM CELL; KIDNEY; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

ADULT; BIOLOGICAL MARKERS; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; FEMALE; FIBROBLAST GROWTH FACTORS; GLUCURONIDASE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY; KIDNEY DISEASES; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; TRANSPLANT RECIPIENTS; VASCULAR DISEASES;

EID: 84910124797     PISSN: 00411345     EISSN: 18732623     Source Type: Journal    
DOI: 10.1016/j.transproceed.2014.09.015     Document Type: Conference Paper

References (20)

1. J. Malyszko, J.S. Malyszko, and M. Mysliwiec Serum neutrophil gelatinase-associated lipocalin correlates with kidney function in renal allograft recipients Clin Transplant 23 2009 681 686
2. J. Ärnlöv, A.C. Carlsson, and J. Sundström Serum FGF23 and risk of cardiovascular events in relation to mineral metabolism and cardiovascular pathology Clin J Am Soc Nephrol 8 2013 781 786
3. M. Wolf Update on fibroblast growth factor 23 in chronic kidney disease Kidney Int 82 2012 737 747
4. O.M. Gutiérrez, M. Mannstadt, and T. Isakova Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis N Engl J Med 359 2008 584 592
5. J. Ärnlöv, A.C. Carlsson, and J. Sundström Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community Kidney Int 83 2013 160 166
6. J. Munoz Mendoza, T. Isakova, and A.C. Ricardo Chronic Renal Insufficiency Cohort. Fibroblast growth factor 23 and Inflammation in CKD Clin J Am Soc Nephrol 7 2012 1155 1162
7. J. Malyszko, J.S. Malyszko, K. Pawlak, and M. Mysliwiec The coagulo-lytic system and endothelial function in cyclosporine-treated kidney allograft recipients Transplantation 62 1996 828 830
8. Modification of Diet in Renal Disease Study Group: Creatinine filtration, secretion and excretion during progressive renal disease Kidney Int 36 1989 S73 S80
9. A.I. Sánchez Fructuoso, M.L. Maestro, and I. Pérez-Flores Serum level of fibroblast growth factor 23 in maintenance renal transplant patients Nephrol Dial Transplant 27 2012 4227 4235
10. M.I. Yilmaz, A. Sonmez, and M. Saglam Longitudinal analysis of vascular function and biomarkers of metabolic bone disorders before and after renal transplantation Am J Nephrol 37 2013 126 344
11. K. Wesseling-Perry, R.C. Pereira, E. Tsai, R. Ettenger, H. Jüppner, and I.B. Salusky FGF23 and mineral metabolism in the early post-renal transplantation period Pediatr Nephrol 28 2013 2207 2215
12. A.I. Sánchez Fructuoso, M.L. Maestro, and N. Calvo Role of fibroblast growth factor 23 (FGF23) in the metabolism of phosphorus and calcium immediately after kidney transplantation Transplant Proc 44 2012 2551 2554
13. M. Wolf, M.Z. Molnar, and A.P. Amaral Elevated fibroblast growth factor 23 is a risk factor for kidney transplant loss and mortality J Am Soc Nephrol 22 2011 956 966
14. J. Bacchetta, L. Dubourg, and J. Harambat The influence of glomerular filtration rate and age on fibroblast growth factor 23 serum levels in pediatric chronic kidney disease J Clin Endocrinol Metab 95 2010 1741 1748
15. M. Wan, C. Smith, and V. Shah Fibroblast growth factor 23 and soluble klotho in children with chronic kidney disease Nephrol Dial Transplant 28 2013 153 161
16. T. Krajisnik, H. Olauson, and M.A. Mirza Parathyroid Klotho and FGF-receptor 1 expression decline with renal function in hyperparathyroid patients with chronic kidney disease and kidney transplant recipients Kidney Int 78 2010 1024 1032
17. L.C. Baia, J.K. Humalda, M.G. Vervloet NIGRAM Consortium Fibroblast growth factor 23 and cardiovascular mortality after kidney transplantation Clin J Am Soc Nephrol 8 2013 1968 1978
18. A. Abbasi, E. Corpeleijn, and E. Meijer Sex differences in the association between plasma copeptin and incident type 2 diabetes: The Prevention of Renal and Vascular End-stage Disease (PREVEND) study Diabetologia 55 2012 1963 1970
19. M.S. Sabatine, D.A. Morrow, and J.A. de Lemos Evaluation of multiple biomarkers of cardiovascular stress for risk prediction and guiding medical therapy in patients with stable coronary disease Circulation 125 2012 233 240
20. V. Shalhoub, E.M. Shatzen, and S.C. Ward FGF23 neutralization improves chronic kidney disease-associated hyperparathyroidism yet increases mortality J Clin Invest 122 2012 2543 2553